Engineers Gate Manager LP Zynerba Pharmaceuticals, Inc. Transaction History

Engineers Gate Manager LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$3.23 - $4.3 $59,222 - $78,840	-18,335 Closed	0 $0
Q2 2020 Aug 17, 2020	BUY	$3.31 - $6.54 $60,688 - $119,910	18,335 New	18,335 $62,000
Q2 2019 Aug 14, 2019	SELL	$5.4 - $15.5 $293,333 - $841,975	-54,321 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$3.6 - $6.22 $82,929 - $143,283	23,036 Added 73.63%	54,321 $294,000
Q4 2018 Feb 14, 2019	SELL	$2.89 - $7.91 $101,106 - $276,731	-34,985 Reduced 52.79%	31,285 $93,000
Q3 2018 Nov 01, 2018	BUY	$5.59 - $10.45 $238,038 - $444,992	42,583 Added 179.77%	66,270 $541,000
Q2 2018 Aug 03, 2018	BUY	$7.98 - $12.39 $189,022 - $293,481	23,687 New	23,687 $231,000
Q4 2017 Feb 01, 2018	SELL	$8.69 - $14.59 $273,430 - $459,074	-31,465 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$5.73 - $9.44 $180,294 - $297,029	31,465	31,465 $263,000

774K

Ticker ZYNE
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,753,100
Description
Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for t...

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

Stay updated on Engineers Gate Manager LP with notifications on news.